Studies on Metamizole, Cyproheptadine and Phenobarbitone Sodium Interaction in Rats

dc.contributor.authorKanniappan, M
dc.contributor.authorSamuel, J.Jayasekaran
dc.contributor.authorNatarajan, R
dc.contributor.authorTANUVAS
dc.date.accessioned2016-08-30T12:47:09Z
dc.date.available2016-08-30T12:47:09Z
dc.date.issued1982
dc.description.abstractThe above findings clearly indicate that analgesic effect of metamizole was reduced or nullified at the dose of 225 mg/kg body weight on simultaneous administration with cyproheptadine at the dose of 0.1 mg/kg body weight, and 72 hours after the administration of phenobarbitone sodium at the dose of 100 mg/kg body weight and cyproheptadine at the dose of 0.1 mg/kg body weight. Hence both in therapy and during surgery, the above drug interactions should be taken into consideration while administering metamizole as an analgesic.en_US
dc.identifier.urihttp://krishikosh.egranth.ac.in/handle/1/74471
dc.language.isoen_USen_US
dc.publisherTANUVASen_US
dc.subjectMetamizoleen_US
dc.subjectCyproheptadineen_US
dc.subjectPhenobarbitone sodiumen_US
dc.subjectRatsen_US
dc.titleStudies on Metamizole, Cyproheptadine and Phenobarbitone Sodium Interaction in Ratsen_US
dc.title.alternativeCheiron Vol.11 Iss.02 Pg.105-107en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
CHE_1982_11_02_105-107.pdf
Size:
160.95 KB
Format:
Adobe Portable Document Format
Description:
CHE_1982_11_02_105-107
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.28 KB
Format:
Item-specific license agreed upon to submission
Description: